The Government is now operating in accordance with the Caretaker Conventions pending the outcome of the 2022 federal election.

Health technology assessments

We use health technology assessments (HTAs) to inform our decisions about which health technologies can be sold in Australia, and which ones qualify for Australian Government subsidy.

Processes

There are 2 main health technology assessment (HTA) processes:

Health technologies must have market authorisation before they can be included in Australian Government–subsidised programs.  

Benefits

Australians benefit from HTAs because they ensure taxpayers’ money supports safe, effective healthcare improvements.

Types of health technology we assess

We use HTAs to assess:

  • pharmaceuticals (including vaccines)
  • diagnostic tests
  • medical devices
  • surgically implanted prostheses
  • medical procedures
  • public health interventions.

Who conducts an HTA

In Australia, several advisory and regulatory bodies provide HTAs and advise us on their findings.

The Therapeutic Goods Administration (TGA) assesses the safety, quality and efficacy of new health technologies entering the Australian market. If they approve an item, they grant market authorisation and the item can be legally sold in Australia.

Three principal health technology advisory committees assess whether health technologies qualify for Australian Government subsidy:

Underlying principles

Our HTA system is guided by the principles outlined in the 2009 report Review of health technology assessment in Australia. HTA processes should be:

  • sustainable
  • transparent, accountable and independent
  • consultative and reflective of Australian community values
  • administratively efficient
  • flexible and fit for purpose
  • informed by robust and relevant evidence.
Last updated: 
13 April 2022

Help us improve health.gov.au

If you would like a response please use the enquiries form instead.